Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|November 21, 2007
The entero-insular axis: implications for human metabolismLakshminarayan R RanganathJournal of Inherited Metabolic Disease|July 13, 2011
Natural history of alkaptonuria revisited: analyses based on scoring systemsLakshminarayan R Ranganath, Trevor F CoxCurrent Rheumatology Reports|October 1, 2014
The role of nitisinone in tyrosine pathway disordersEdward Lock, Lakshminarayan R Ranganath, Oliver TimmisCurrent Opinion in Pharmacology|May 16, 2015
Lessons from rare diseases of cartilage and boneJames A Gallagher, Lakshminarayan R Ranganath, Alan BoydeRheumatology and Immunology Research|December 5, 2022
Development of an Effective Therapy for Alkaptonuria - Lessons for OsteoarthritisJames A Gallagher, Jane P Dillon, Lakshminarayan R RanganathJournal of Clinical Pathology|March 15, 2013
Recent advances in management of alkaptonuria (invited review; best practice article)Lakshminarayan R Ranganath, Jonathan C Jarvis, James A GallagherGait & Posture|November 15, 2016
Interpreting sources of variation in clinical gait analysis: A case studyStephanie L King, Gabor J Barton, Lakshminarayan R RanganathMetabolites|June 26, 2024
Correction: Zatkova et al. Analysis of the Phenotype Differences in Siblings with Alkaptonuria. Metabolites 2022, 12, 990Andrea Zatkova, Birgitta Olsson, Lakshminarayan R Ranganath, et al.Metabolites|October 27, 2022
Analysis of the Phenotype Differences in Siblings with AlkaptonuriaAndrea Zatkova, Birgitta Olsson, Lakshminarayan R Ranganath, et al.Journal of Inherited Metabolic Disease|July 9, 2019
Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A reviewLakshminarayan R Ranganath, Brendan P Norman, James A GallagherPageof 7